Cargando…

Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer

BACKGROUND: Urine markers have been studied extensively but there is a lack of blood prognostic markers in bladder cancer. MMP-7 is produced by stromal cells and by tumor cells and is overexpressed in a variety of epithelial and mesenchymal tumors. In this study, we assessed with an immunoassay we d...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Demery, Mounira, Demirdjian-Sarkissian, Gaiané, Thezenas, Simon, Jacot, William, Laghzali, Yassine, Darbouret, Bruno, Culine, Stéphane, Rebillard, Xavier, Lamy, Pierre-Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4410142/ https://www.ncbi.nlm.nih.gov/pubmed/25984271 http://dx.doi.org/10.1186/s40169-014-0031-4

Ejemplares similares

First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum marker
por: Tørring, Niels, et al.
Publicado: (2010)

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
por: Darlix, Amélie, et al.
Publicado: (2016)

Matrix Metalloproteinases and Bladder Cancer: What is New?
por: Rodriguez Faba, O., et al.
Publicado: (2012)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
por: Bolenz, Christian, et al.
Publicado: (2018)

Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
por: Culine, Stéphane, et al.
Publicado: (2018)

Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis
por: Chen, Chen, et al.
Publicado: (2020)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Enhanced Expression but Decreased Specific Activity of Matrix Metalloproteinase 10 (MMP-10) in Comparison with Matrix Metalloproteinase 3 (MMP-3) in Human Urinary Bladder Carcinoma
por: Kudelski, Jacek, et al.
Publicado: (2021)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles
por: Jacot, William, et al.
Publicado: (2011)

Prognostic role of matrix metalloproteinases in bladder carcinoma: a systematic review and meta-analysis
por: Miao, Chenkui, et al.
Publicado: (2017)

Curcumin May Prevent Basement Membrane Disassembly by Matrix Metalloproteinases and Progression of the Bladder Cancer
por: Wroński, Paweł, et al.
Publicado: (2021)

The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation
por: Wu, Gang, et al.
Publicado: (2016)

Imbalances between Matrix Metalloproteinases (MMPs) and Tissue Inhibitor of Metalloproteinases (TIMPs) in Maternal Serum during Preterm Labor
por: Tency, Inge, et al.
Publicado: (2012)

Androgenic hormones and the excess male mortality observed in COVID-19 patients: new convergent data
por: Lamy, Pierre-Jean, et al.
Publicado: (2020)

Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer
por: Mohammed, Mohammed A, et al.
Publicado: (2013)

High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker
por: Papadakos, Konstantinos S., et al.
Publicado: (2019)

Matrix Metalloproteinases in Cerebral Ischemia
por: Kim, Hahn Young, et al.
Publicado: (2006)

Matrix metalloproteinases in arthritic disease
por: Murphy, Gillian, et al.
Publicado: (2002)

Matrix metalloproteinases in lung biology
por: Parks, William C, et al.
Publicado: (2001)

Matrix metalloproteinases in exercise and obesity
por: Jaoude, Jonathan, et al.
Publicado: (2016)

Matrix Metalloproteinases and Glaucoma Treatment
por: Weinreb, Robert N., et al.
Publicado: (2020)

Challenges in Matrix Metalloproteinases Inhibition
por: Laronha, Helena, et al.
Publicado: (2020)

Matrix Metalloproteinases in Health and Disease
por: Serra, Raffaele
Publicado: (2020)

Matrix metalloproteinases in keratinocyte carcinomas
por: Riihilä, Pilvi, et al.
Publicado: (2020)

Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissuenhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase
por: Collins, H M, et al.
Publicado: (2001)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration
por: Zeng, Renpan, et al.
Publicado: (2013)

Role of serum matrix metalloproteinase in the diagnosis of gastric cancer
por: Liu, Jian, et al.
Publicado: (2020)

Matrix Metalloproteinase Mediated Type I Collagen Degradation — An Independent Risk Factor for Mortality in Women
por: Dragsbæk, K., et al.
Publicado: (2015)

Assessment of serum concentrations of matrix metalloproteinase 1, matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases 1 in atopic dermatitis in correlation with disease severity and epidermal barrier parameters
por: Basałygo, Magdalena, et al.
Publicado: (2021)

Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
por: Viala, Marie, et al.
Publicado: (2018)

Disseminated Intravascular Coagulation with Enhanced Fibrinolysis Caused by Heart Metastasis of Bladder Urothelial Carcinoma
por: Helal, Clara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o460ugpkgtttq74j5fpnia0i9n